Case Report
Cerebellar Dysfunction in a Patient with HIV
Table 1
Shows the demographic and clinical findings, treatment, and outcome of JC virus granule cell neuronopathy reported in the literature.
| Author | Age | Sex | Primary condition | Location of lesion | Treatment | Outcome |
| Hecht et al. [8] | 15 | M | Hyper IgM Type I | Cerebellar hemisphere and vermis | Cidofovir | Nonambulatory | Wüthrich et al. [9] | 74 | M | Non-small cell lung cancer on chemotherapy | Cerebellar hemisphere | Prednisone | Deceased 4.5 mos after diagnosis | Granot et al. [4] | 49 | F | Sarcoidosis | Left cerebellar hemisphere | HAART therapy | Deceased few weeks after diagnosis | Tan and Brew [3] | 42 | M | HIV | Cerebellar hemisphere | HAART therapy and Mefloquine | Deceased 2 years after diagnosis | Koralnik et al. [2] | 43 | F | HIV | Cerebellar hemisphere | HAART therapy | Deceased 13 years after diagnosis | Dang et al. [7] | 25 | F | HIV | Right cerebellar hemisphere | HAART therapy | Deceased 4 mos after diagnosis | Dang et al. [7] | 34 | F | HIV | Cerebellar hemisphere | HAART therapy | Lost in f/u 18 mos after diagnosis | Shang et al. [10] | 58 | F | HIV and hyper-IgE syndrome | Bilateral middle cerebellar peduncles | HAART therapy | Unchanged in examination after 10 wks |
|
|